InsidersTradesSigma
Discover the detailed record of transactions filed by D'Souza Rupert, 首席财务官. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 1 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €8k. History available since 13 May 2022. The latest transaction was filed on 13 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
D'Souza Rupert is the Chief Financial Officer of Adverum Biotechnologies, Inc. He oversees the company's financial strategy, including financial planning, risk management, and financial reporting. His role is crucial in ensuring the financial health of the company and supporting its growth and development.